NVST — Envista Holdings Corporation stock price and chart

NVST

$22.97+1.59%

as of close, Oct 20, 2026

☾ AH $22.97 +1.59%

Envista Holdings CorporationStock · HealthcareRussell 1000 · 0.006% of IWBUS Stock Market · 0.006% of VTIRussell 3000 · 0.006% of IWV

PeersALGNCOOSPYQQQNVDAAAPL

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Sep 23, 2019

VolumeEEEEEEEEEEEE

20192021202320252026

15.020.025.030.035.040.045.050.0020.0M40.0M$22.97

2026-10-20

Price$22.97

MA20$25.78

MA50$25.71

Vol7.4M

What would $1,000 invested in NVST be worth today? →

NVST returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $22.97
YTD price return: +5.80%
YTD total return: +5.80%
Next earnings: Nov 4, 2026 · After close
Market cap: 3.7B2019-09 4.4B2026-10 3.7B-16.6% over the window
Enterprise value: 4.1B
Shares outstanding: 160.6M2017-12 127.9M2026-07 160.6M+25.6% over the window
52W low: $18.77
52W high: $30.42
From 52W high: -24.49%
From 52W low: +22.38%
52W range: 36%

Volume

Rel volume: 1.65×
30D volume: 3M
30D $ vol: 70.2M

Fundamentals

Sales (ttm): 2.9B2017-12 2.8B2026-07 2.9B+1.6% over the window
Sales/share: $17.782017-12 $21.982026-07 $17.78-19.1% over the window
EPS (ttm): $0.572017-12 $2.352026-07 $0.57-75.6% over the window
FCF (ttm): 248.1M2017-12 310.2M2026-07 248.1M-20.0% over the window
FCF/share: $1.542017-12 $2.432026-07 $1.54-36.3% over the window
Book value/share: $19.152018-09 $38.562026-07 $19.15-50.3% over the window
Net margin: 3.33%2017-12 10.7%2026-07 3.3%-69.0% over the window
ROE: 3.09%2018-12 4.8%2026-07 3.1%-35.4% over the window
ROA: 1.70%2017-12 5.0%2026-07 1.7%-66.2% over the window
Debt / equity: 0.47×2018-12 0.002026-07 0.47
Current ratio: 2.432018-12 1.232026-07 2.43+97.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +11.70%2025-06-27 → 2026-07-032.6B → 2.9B (+11.9% total)+3.42%2023-06-30 → 2026-07-032.6B → 2.9B (+10.7% total)+3.43%2021-07-02 → 2026-07-032.4B → 2.9B (+18.4% total)n/a
Net income: +75.03%2025-06-27 → 2026-07-0353.8M → 95M (+76.6% total)-23.98%2023-06-30 → 2026-07-03216.8M → 95M (-56.2% total)-20.84%2021-07-02 → 2026-07-03305.8M → 95M (-68.9% total)n/a
FCF: -3.74%2025-06-27 → 2026-07-03257.9M → 248.1M (-3.8% total)+15.74%2023-06-30 → 2026-07-03159.8M → 248.1M (+55.3% total)-10.16%2021-07-02 → 2026-07-03424M → 248.1M (-41.5% total)n/a
Shares: -3.30%2025-06-27 → 2026-07-03166.2M → 160.6M (-3.3% total)-0.65%2023-06-30 → 2026-07-03163.8M → 160.6M (-2.0% total)-0.08%2021-07-02 → 2026-07-03161.3M → 160.6M (-0.4% total)n/a

Per-share growth (CAGR, ttm) · 10Y

EPS: +81.90%2025-06-27 → 2026-07-03$0.31 → $0.57 (+83.6% total)-22.37%2023-06-30 → 2026-07-03$1.23 → $0.57 (-53.3% total)-18.54%2021-07-02 → 2026-07-03$1.60 → $0.57 (-64.2% total)n/a
Sales/share: +15.51%2025-06-27 → 2026-07-03$15.36 → $17.78 (+15.8% total)+4.10%2023-06-30 → 2026-07-03$15.76 → $17.78 (+12.9% total)+3.51%2021-07-02 → 2026-07-03$14.97 → $17.78 (+18.8% total)n/a
FCF/share: -0.46%2025-06-27 → 2026-07-03$1.55 → $1.54 (-0.5% total)+16.51%2023-06-30 → 2026-07-03$0.98 → $1.54 (+58.4% total)-10.09%2021-07-02 → 2026-07-03$2.63 → $1.54 (-41.3% total)n/a
Book value/share: +1.38%2025-06-27 → 2026-07-03$18.89 → $19.15 (+1.4% total)-10.02%2023-06-30 → 2026-07-03$26.31 → $19.15 (-27.2% total)-4.40%2021-07-02 → 2026-07-03$23.99 → $19.15 (-20.2% total)n/a
Price: +14.06%2025-10-20 → 2026-10-20$20.14 → $22.97 (+14.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-2.51%2023-10-20 → 2026-10-20$24.79 → $22.97 (-7.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-10.01%2021-10-20 → 2026-10-20$38.92 → $22.97 (-41.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +14.06%2025-10-20 → 2026-10-20$20.14 → $22.97 (+14.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-2.51%2023-10-20 → 2026-10-20$24.79 → $22.97 (-7.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-10.01%2021-10-20 → 2026-10-20$38.92 → $22.97 (-41.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 40.0×2019-09 20.802026-10 38.84+86.8% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 13.5×2019-09 16.562026-10 13.48-18.6% over the window
Fwd P/E: 13.6×
P/S (ttm)Market cap ÷ TTM revenue.: 1.3×2019-09 1.592026-10 1.29-18.5% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.2×2019-09 1.262026-10 1.20-4.8% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 14.9×2019-09 14.452026-10 14.87+2.9% over the window
EV/EBITDA (fy): 10.7×
EV/Sales (ttm): 1.5×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 6.72%2019-09 6.9%2026-07 5.8%-16.4% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-07-03) ÷ shares_at(2025-06-27) = 1 − 160.6M ÷ 166.2M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 3.30%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (3.30%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-27) ($3.3B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 3.30%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($169.3M) ÷ today's market cap ($3.7B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 4.59%2019-09 -14.5%2026-07 3.9%-127.1% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $169.3M + TTM dividends $0) ÷ today's market cap ($3.7B). Same caveat as the cash buyback yield.: 4.59%2019-09 -14.5%2026-07 3.9%-127.1% over the window

Vs own 10Y history

P/E: 62nd
P/OI: 6th
P/S: 17th
P/B: 41st
P/FCF: 34th

Bar = where today’s multiple sits in NVST’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+1.59%

+1.41%

-1.63%

-13.58%

YTD

+5.80%

+14.05%

-40.98%

Financial statements

Open full NVST financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

NVST — Envista Holdings Corporation price, chart and key statistics